Effects of agmatine on neuronal discharges in rat hippocampal CA1 area

Acta Physiologica Sinica

Volumn 55, Issue 6, 2003, Pages 717-721

  Wang, Ze Min ^a   Sun, Guang Qi ^a   Wang, Zhi An ^a   He, Rui Rong ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Agmatine; Bay K8644; Hippocampal slices; L glutamate; NG nitro L arginine methyl ester

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AGMATINE; CALCIUM; CALCIUM CHANNEL L TYPE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; EPILEPTIC DISCHARGE; HIPPOCAMPUS; INFLAMMATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; RAT; SPINAL CORD INJURY;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; AGMATINE; ANIMALS; CALCIUM CHANNEL AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NEURONS; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0348223990     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994;263:966-969.
2. Sastre M, Regunanthan S, Galea E, Reis DJ. Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J Neurochem 1996;67:1761-1765.
3. Reis DJ, Yang XC, Milner TA. Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci Lett 1998;250:185-188.
4. Reis DJ, Regunanthan S. Agmatine: A novel neurotransmitter in catecholamines. In: Goldstein DS, Eisenhofer G, Mccarty R eds. Bridging Basic Science with Clinical Medicine, Academic Press, San Diego 1997;645-649.
5. Reis DJ, Regunanthan S. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter. Ann N Y Acad Sci 1999;21:88165-88180.
6. Gilad GM, Salame K, Rabey JM, Gilad VH. Agmatine treatment is neuroprotective in rodent brain injury. Life Sci 1996;58:41-46.
7. Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, H. Oanh Nguyen H, Grocholski BH, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GL. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA 2000;97:10584-10589.
8. Li J, Li X, Pei G, Qin BY. Effects of agmatine on tolerance to and substance dependence on morphine in mice. Acta Pharmacol Sin 1999;20:232-238.
9. Yang XC, Reis DJ. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999;288:544-549.
10. Xue BJ, Wang ZA, He RR. Effects of NO precursor and donor on neuronal activity of rat hippocampal slices. Acta Physiol Sin 1997;49(4):375-381 (Chinese, English abstract).
11. Hablitz JJ, Langmeon IA. N-methyl-D-aspartate receptor antagonists reduce synaptic excitation in hippocampus. J Neurosci 1986;6:102-106.
12. Fisher RS, Glutamate and epilepsy. In: Fisher RS, Coyle JT, eds. Neurotransmitters and Epilepsy. New York, Wiley-Liss 1991;131-135.
13. Johnson JW, Ascher D. Glycine potentiates the NMDA response in cultured mouses brain neurons. Nature 1987;325:529-531.
14. Collingridge GL, Kehl SJ, Mclennan H. The antagonism of amino acid-induced excitations of rat hippocampal CA1 neurons in vitro. J Physiol 1983;334:19-31.
15. Merlin LR, Tayler GM, Wong RK. Role of metabotropic glutamate receptor subtypes in the patterning of epileptiform activities in vitro. J Neurophysiol 1995;74:896-900.
16. Xue BJ, Wang ZA, He RR. Inhibitory effects of nitric oxide on glutamate-induced neuronal activity of CA1 area in rat hippocampal slices. Acta Physiol Sin 1998;50(1):55-60 (Chinese, English abstract).
17. Wang H, Wang ZA, He RR. Adenosine inhibits spontaneous and glutamate-induced discharges of hippocampal CA1 neurons. Acta Physiol Sin 2000;52(4):281-286 (Chinese, English abstract).
18. Lysko PG, Cox JA, Vigano A, Henneberry RC. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological charaterization. Brain Res 1989;499:258-266.
19. Gabriel O, Nuria DR, M. Paz R, Teresa G, M. Assunpcio B, Ramon T, Alvaro V, Juan L, Jesús A. G-S. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Bri J pharmacol 1999;127:1317-1326.
20. 2+ in individual cerebellar granule neurons-role in neurotoxicity. J Neurosci Res 1991;28:434-441.
21. Bon CL, Garthwaite J. On the role of nitric oxide in hippocampal long-term potentiation. J Neurosci 2003;23:1941-1948.
22. Tanaka T, Saito H, Matsuki N. Endogenous nitric oxide inhibits NMDA- and kainate-responses by a negative feedback system in rat hippocampal neurons. Brain Res 1993;631:72-76.
23. Manzini O, Bockaert J. Nitric oxide synthase activity endogenously modulates NMDA receptors. J Neurochem 1993;61:368-370.
24. Ishikawa T, Misonou T, Ikeno M, Sato K, Sakamaki T. N omega-hydroxyagmatine: a novel substance causing endothenlium-dependent vasorelaxation. Biochem Biophys Res Commun 1995;214:145-151.
25. Galea E, Regunathan S, Eliopoulos V, Feinstein D. J, Reis D. J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996;316:247-249.